No. . | Review . | Methods tested . | Datasets . | Database (# of gene sets/pathways) . | Types of evaluated methods . |
---|---|---|---|---|---|
1 | [13] | 7 | 36 | KEGG (116) | Topology- and non-topology-based methods |
2 | [2] | 10 | 75 | KEGG (323) and GO (4631) | ORA and FCS methods |
3 | [3] | 7 | 118 | KEGG (232) | Topology-based methods |
4 | [14] | 6 | 20 | KEGG (86) | Topology- and non-topology-based methods |
5 | [15] | 9 | 3 | KEGG (114) | Topology-based methods |
6 | [16] | 13 | 6 | GO gene set collection extracted from MSigDB [17] v6.1 (5917) | Widely used pathway enrichment methods |
7 | [18] | 8 | 3 | MSigDB v5.0 (10,295) | Widely used pathway enrichment methods |
8 | [9] | 10 | 86 | KEGG; 150 pathways for all methods except 130 for PathNet [19] and 186 for CePa [20, 21] | Topology- and non-topology-based methods |
9 | [22] | 11 | 1 | C2 collection from MSigDB v4.0 (4722) | Methods differing based on null hypothesis |
10 | [23] | 16 | 42 | KEGG (259) and Metacore™ (88) | ORA and FCS methods |
11 | [24] | 5 | 6 | KEGG (192) | ORA and FCS methods |
12 | [25] | 7 | 38 | KEGG (189) | ORA and FCS methods |
No. . | Review . | Methods tested . | Datasets . | Database (# of gene sets/pathways) . | Types of evaluated methods . |
---|---|---|---|---|---|
1 | [13] | 7 | 36 | KEGG (116) | Topology- and non-topology-based methods |
2 | [2] | 10 | 75 | KEGG (323) and GO (4631) | ORA and FCS methods |
3 | [3] | 7 | 118 | KEGG (232) | Topology-based methods |
4 | [14] | 6 | 20 | KEGG (86) | Topology- and non-topology-based methods |
5 | [15] | 9 | 3 | KEGG (114) | Topology-based methods |
6 | [16] | 13 | 6 | GO gene set collection extracted from MSigDB [17] v6.1 (5917) | Widely used pathway enrichment methods |
7 | [18] | 8 | 3 | MSigDB v5.0 (10,295) | Widely used pathway enrichment methods |
8 | [9] | 10 | 86 | KEGG; 150 pathways for all methods except 130 for PathNet [19] and 186 for CePa [20, 21] | Topology- and non-topology-based methods |
9 | [22] | 11 | 1 | C2 collection from MSigDB v4.0 (4722) | Methods differing based on null hypothesis |
10 | [23] | 16 | 42 | KEGG (259) and Metacore™ (88) | ORA and FCS methods |
11 | [24] | 5 | 6 | KEGG (192) | ORA and FCS methods |
12 | [25] | 7 | 38 | KEGG (189) | ORA and FCS methods |
In the third column, we report the number of enrichment methods compared in each study (see Supplementary Tables 2 and 3, available online at https://dbpia.nl.go.kr/bib, for details on the methods tested). Here, we would like to note that we differentiate between methods and tools/web applications based on Geistlinger et al. [2]. In the fourth column, we report the number of datasets each study performed comparisons on, all of which were experimental datasets except in [3, 13, 14, 18, 22], which included both experimental and simulated datasets. Finally, the fifth column reports the pathway databases used in each study while the number of pathways is shown between parentheses.
No. . | Review . | Methods tested . | Datasets . | Database (# of gene sets/pathways) . | Types of evaluated methods . |
---|---|---|---|---|---|
1 | [13] | 7 | 36 | KEGG (116) | Topology- and non-topology-based methods |
2 | [2] | 10 | 75 | KEGG (323) and GO (4631) | ORA and FCS methods |
3 | [3] | 7 | 118 | KEGG (232) | Topology-based methods |
4 | [14] | 6 | 20 | KEGG (86) | Topology- and non-topology-based methods |
5 | [15] | 9 | 3 | KEGG (114) | Topology-based methods |
6 | [16] | 13 | 6 | GO gene set collection extracted from MSigDB [17] v6.1 (5917) | Widely used pathway enrichment methods |
7 | [18] | 8 | 3 | MSigDB v5.0 (10,295) | Widely used pathway enrichment methods |
8 | [9] | 10 | 86 | KEGG; 150 pathways for all methods except 130 for PathNet [19] and 186 for CePa [20, 21] | Topology- and non-topology-based methods |
9 | [22] | 11 | 1 | C2 collection from MSigDB v4.0 (4722) | Methods differing based on null hypothesis |
10 | [23] | 16 | 42 | KEGG (259) and Metacore™ (88) | ORA and FCS methods |
11 | [24] | 5 | 6 | KEGG (192) | ORA and FCS methods |
12 | [25] | 7 | 38 | KEGG (189) | ORA and FCS methods |
No. . | Review . | Methods tested . | Datasets . | Database (# of gene sets/pathways) . | Types of evaluated methods . |
---|---|---|---|---|---|
1 | [13] | 7 | 36 | KEGG (116) | Topology- and non-topology-based methods |
2 | [2] | 10 | 75 | KEGG (323) and GO (4631) | ORA and FCS methods |
3 | [3] | 7 | 118 | KEGG (232) | Topology-based methods |
4 | [14] | 6 | 20 | KEGG (86) | Topology- and non-topology-based methods |
5 | [15] | 9 | 3 | KEGG (114) | Topology-based methods |
6 | [16] | 13 | 6 | GO gene set collection extracted from MSigDB [17] v6.1 (5917) | Widely used pathway enrichment methods |
7 | [18] | 8 | 3 | MSigDB v5.0 (10,295) | Widely used pathway enrichment methods |
8 | [9] | 10 | 86 | KEGG; 150 pathways for all methods except 130 for PathNet [19] and 186 for CePa [20, 21] | Topology- and non-topology-based methods |
9 | [22] | 11 | 1 | C2 collection from MSigDB v4.0 (4722) | Methods differing based on null hypothesis |
10 | [23] | 16 | 42 | KEGG (259) and Metacore™ (88) | ORA and FCS methods |
11 | [24] | 5 | 6 | KEGG (192) | ORA and FCS methods |
12 | [25] | 7 | 38 | KEGG (189) | ORA and FCS methods |
In the third column, we report the number of enrichment methods compared in each study (see Supplementary Tables 2 and 3, available online at https://dbpia.nl.go.kr/bib, for details on the methods tested). Here, we would like to note that we differentiate between methods and tools/web applications based on Geistlinger et al. [2]. In the fourth column, we report the number of datasets each study performed comparisons on, all of which were experimental datasets except in [3, 13, 14, 18, 22], which included both experimental and simulated datasets. Finally, the fifth column reports the pathway databases used in each study while the number of pathways is shown between parentheses.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.